On the public citation graph
Comparison of seroprevalence of SARS-CoV-2 infections with cumulative and imputed COVID-19 cases: Systematic review
0 signed · 294 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1001/jama.2020.8279openalex-snapshot
Seroprevalence of SARS-CoV-2–Specific Antibodies Among Adults in Los Angeles County, California, on April 10-11, 2020
inferredcites →https://doi.org/10.1001/jamainternmed.2020.4130openalex-snapshot
Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020
inferredcites →https://doi.org/10.1002/14651858.cd013652openalex-snapshot
Antibody tests for identification of current and past infection with SARS-CoV-2
inferredcites →https://doi.org/10.1002/14651858.cd013652.pub2openalex-snapshot
Antibody tests for identification of current and past infection with SARS-CoV-2
inferredcites →https://doi.org/10.1002/14651858.cd013665openalex-snapshot
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 disease
inferredcites →https://doi.org/10.1002/jgf2.408openalex-snapshot
Seroprevalence of SARS‐CoV‐2 in Utsunomiya City, Greater Tokyo, after the first pandemic in 2020
inferredcites →https://doi.org/10.1007/s10654-020-00698-1openalex-snapshot
Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications
inferredcites →https://doi.org/10.1007/s11357-020-00226-9openalex-snapshot
Novel coronavirus epidemic in the Hungarian population, a cross-sectional nationwide survey to support the exit policy in Hungary
inferredcites →https://doi.org/10.1016/j.cmi.2020.11.009openalex-snapshot
Antibody response using six different serological assays in a completely PCR-tested community after a coronavirus disease 2019 outbreak—the CoNAN study
inferredcites →https://doi.org/10.1016/j.ijid.2020.02.060openalex-snapshot
Serial interval of novel coronavirus (COVID-19) infections
inferredcites →https://doi.org/10.1016/j.ijid.2020.09.1464openalex-snapshot
A systematic review and meta-analysis of published research data on COVID-19 infection fatality rates
inferredcites →https://doi.org/10.1016/j.jclinepi.2011.11.014openalex-snapshot
Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement
inferredcites →https://doi.org/10.1016/j.jclinepi.2020.01.008openalex-snapshot
A full systematic review was completed in 2 weeks using automation tools: a case study
inferredcites →https://doi.org/10.1016/j.jmii.2020.03.015openalex-snapshot
Duration of serum neutralizing antibodies for SARS-CoV-2: Lessons from SARS-CoV infection
inferredcites →https://doi.org/10.1016/j.tmaid.2020.101673openalex-snapshot
Detection and analysis of nucleic acid in various biological samples of COVID-19 patients
inferredcites →https://doi.org/10.1016/s0140-6736(20)31304-0openalex-snapshot
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study
inferredcites →https://doi.org/10.1016/s0140-6736(20)31483-5openalex-snapshot
Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study
inferredcites →https://doi.org/10.1016/s1473-3099(20)30764-7openalex-snapshot
Genomic evidence for reinfection with SARS-CoV-2: a case study
inferredcites →https://doi.org/10.1016/s1473-3099(20)30783-0openalex-snapshot
What reinfections mean for COVID-19
inferredcites →https://doi.org/10.1038/s41467-020-19509-yopenalex-snapshot
Infection fatality rate of SARS-CoV2 in a super-spreading event in Germany
inferredcites →https://doi.org/10.1038/s41467-021-23893-4openalex-snapshot
Multianalyte serology in home-sampled blood enables an unbiased assessment of the immune response against SARS-CoV-2
inferredcites →https://doi.org/10.1038/s41586-020-2012-7openalex-snapshot
A pneumonia outbreak associated with a new coronavirus of probable bat origin
inferredcites →https://doi.org/10.1038/s41591-020-0897-1openalex-snapshot
Antibody responses to SARS-CoV-2 in patients with COVID-19
inferredcites →https://doi.org/10.1038/s41591-020-0965-6openalex-snapshot
Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections
inferredcites →https://doi.org/10.1038/s41591-020-0992-3openalex-snapshot
Population-based surveys of antibodies against SARS-CoV-2 in Southern Brazil
inferredcites →https://doi.org/10.1056/nejmc070348openalex-snapshot
Disappearance of Antibodies to SARS-Associated Coronavirus after Recovery
inferredcites →https://doi.org/10.1056/nejmoa2026116openalex-snapshot
Humoral Immune Response to SARS-CoV-2 in Iceland
inferredcites →https://doi.org/10.1059/0003-4819-155-8-201110180-00009openalex-snapshot
QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies
inferredcites →https://doi.org/10.1101/2020.05.11.20092916openalex-snapshot
Prevalence of SARS-CoV-2 infection in the Luxembourgish population: the CON-VINCE study.
inferredcites →https://doi.org/10.1101/2020.05.17.20104554openalex-snapshot
The true case fatality of COVID-19: An analytical solution
inferredcites →https://doi.org/10.1101/2020.05.30.20117531openalex-snapshot
Remarkable variability in SARS-CoV-2 antibodies across Brazilian regions: nationwide serological household survey in 27 states
inferredcites →https://doi.org/10.1101/2020.07.14.20153858openalex-snapshot
Community-level SARS-CoV-2 Seroprevalence Survey in urban slum dwellers of Buenos Aires City, Argentina: a participatory research
inferredcites →https://doi.org/10.1136/bmj.m2516openalex-snapshot
Diagnostic accuracy of serological tests for covid-19: systematic review and meta-analysis
inferredcites →https://doi.org/10.2139/ssrn.3680955openalex-snapshot
Genomic Evidence for a Case of Reinfection with SARS-CoV-2
inferredcites →https://doi.org/10.2471/blt.20.265892openalex-snapshot
Infection fatality rate of COVID-19 inferred from seroprevalence data
inferredcites →https://doi.org/10.3138/jammi-2020-0030openalex-snapshot
Estimating the extent of asymptomatic COVID-19 and its potential for community transmission: Systematic review and meta-analysis
inferredcites →https://doi.org/10.3201/eid2607.200282openalex-snapshot
High Contagiousness and Rapid Spread of Severe Acute Respiratory Syndrome Coronavirus 2
inferredcites →https://doi.org/10.3201/eid2611.202736openalex-snapshot
Seroprevalence of SARS-CoV-2–Specific Antibodies, Faroe Islands
inferredcites →https://doi.org/10.3201/eid2702.201960openalex-snapshot
Seroprevalence of SARS-CoV-2 in Guilan Province, Iran, April 2020
inferredcites →https://doi.org/10.46945/bpj.10.1.03.01openalex-snapshot
WHO Coronavirus Disease (COVID-19) Dashboard
inferredcites →https://doi.org/10.5195/jmla.2020.834openalex-snapshot
Improving the translation of search strategies using the Polyglot Search Translator: a randomized controlled trial
inferredcites →https://doi.org/10.7326/0003-4819-155-8-201110180-00009openalex-snapshot
QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2020.35057openalex-snapshot
SARS-CoV-2 Transmission From People Without COVID-19 Symptoms
inferred← citeshttps://doi.org/10.1002/9781119812234.ch8openalex-snapshot
Biomedical Research and Program Evaluation
inferred← citeshttps://doi.org/10.1002/jmv.27486openalex-snapshot
SARS‐CoV‐2 antibody kinetics in blood donors with a previously positive SARS‐CoV‐2 antibody test within a seroprevalence survey
inferred← citeshttps://doi.org/10.1002/jmv.71040openalex-snapshot
How Many Veteran COVID‐19 Cases Were There during the Pandemic?
inferred← citeshttps://doi.org/10.1007/978-3-031-20537-8_13openalex-snapshot
Nano-Drug Delivery Systems for COVID-19 Drug Delivery
inferred← citeshttps://doi.org/10.1007/s00477-021-02081-2openalex-snapshot
Underdetection in a stochastic SIR model for the analysis of the COVID-19 Italian epidemic
inferred← citeshttps://doi.org/10.1007/s00508-021-01974-0openalex-snapshot
Leitlinie S1: Long COVID: Differenzialdiagnostik und Behandlungsstrategien
inferred← citeshttps://doi.org/10.1007/s10654-020-00698-1openalex-snapshot
Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications
inferred← citeshttps://doi.org/10.1007/s11030-022-10405-9openalex-snapshot
Defective ORF8 dimerization in SARS-CoV-2 delta variant leads to a better adaptive immune response due to abrogation of ORF8-MHC1 interaction
inferred← citeshttps://doi.org/10.1007/s15010-021-01629-2openalex-snapshot
SARS-CoV-2: big seroprevalence data from Pakistan—is herd immunity at hand?
inferred← citeshttps://doi.org/10.1007/s15010-023-02011-0openalex-snapshot
Seroprevalence trends of anti-SARS-CoV-2 antibodies and associated risk factors: a population-based study
inferred← citeshttps://doi.org/10.1016/bs.armc.2026.08.007openalex-snapshot
Small-molecule drug conjugates as a novel strategy against emerging respiratory viruses, such as influenza viruses and SARS-CoV-2
inferred← citeshttps://doi.org/10.1016/j.cmi.2021.09.019openalex-snapshot
Update on SARS-CoV-2 seroprevalence: regional and worldwide
inferred← citeshttps://doi.org/10.1016/j.idm.2022.11.001openalex-snapshot
Modeling the impact of surveillance activities combined with physical distancing interventions on COVID-19 epidemics at a local level
inferred← citeshttps://doi.org/10.1016/j.ijid.2021.03.030openalex-snapshot
COVID-19: Is herd immunity the only option for fragile Yemen?
inferred← citeshttps://doi.org/10.1016/j.ijid.2022.03.043openalex-snapshot
Serological surveillance of healthcare workers to evaluate natural infection- and vaccine-derived immunity to SARS-CoV-2 during an outbreak in Dili, Timor-Leste
inferred← citeshttps://doi.org/10.1016/j.jclinepi.2023.03.007openalex-snapshot
We extended the 2-week systematic review (2weekSR) methodology to larger, more complex systematic reviews: A case series
inferred← citeshttps://doi.org/10.1016/j.jcvp.2026.100242openalex-snapshot
Clinical evaluation of the BD Veritor™ SARS-CoV-2 point-of-care test
inferred← citeshttps://doi.org/10.1016/j.procbio.2023.01.018openalex-snapshot
Convalescent plasma (hyperimmune immunoglobulin) for COVID-19 management: An update
inferred← citeshttps://doi.org/10.1016/j.scitotenv.2021.145530openalex-snapshot
Disposable face masks and reusable face coverings as non-pharmaceutical interventions (NPIs) to prevent transmission of SARS-CoV-2 variants that cause coronavirus disease (COVID-19): Role of new sustainable NPI design innovations and predictive mathematical modelling
inferred← citeshttps://doi.org/10.1016/j.scitotenv.2021.152597openalex-snapshot
Association of SARS-CoV-2 presence in sewage with public adherence to precautionary measures and reported COVID-19 prevalence in Tehran
inferred← citeshttps://doi.org/10.1016/s2666-5247(22)00114-8openalex-snapshot
Estimating typhoid incidence from community-based serosurveys: a multicohort study
inferred← citeshttps://doi.org/10.1038/s41467-022-31753-yopenalex-snapshot
An analysis of 45 large-scale wastewater sites in England to estimate SARS-CoV-2 community prevalence
inferred← citeshttps://doi.org/10.1038/s41577-020-00451-5openalex-snapshot
COVID-19 herd immunity: where are we?
inferred← citeshttps://doi.org/10.1038/s41598-021-85555-1openalex-snapshot
Vaccination strategies against COVID-19 and the diffusion of anti-vaccination views
inferred← citeshttps://doi.org/10.1038/s41598-022-04899-4openalex-snapshot
Iterative data-driven forecasting of the transmission and management of SARS-CoV-2/COVID-19 using social interventions at the county-level
inferred← citeshttps://doi.org/10.1055/a-1769-2759openalex-snapshot
Der lange Weg zurück – Long COVID
inferred← citeshttps://doi.org/10.1080/23744235.2021.2003856openalex-snapshot
Increased SARS-CoV-2 seroprevalence in healthy blood donors after the second pandemic wave in South-Eastern Italy: evidence for asymptomatic young donors as potential virus spreaders
inferred← citeshttps://doi.org/10.1080/23744235.2022.2035429openalex-snapshot
Incidence of SARS-CoV-2 infection in a cohort of workers from the University of Porto, Portugal
inferred← citeshttps://doi.org/10.1080/23744235.2023.2179660openalex-snapshot
COVID-19: seroprevalence and adherence to preventive measures in Arkhangelsk, Northwest Russia
inferred← citeshttps://doi.org/10.1089/vbz.2022.0003openalex-snapshot
SARS-CoV-2 Seroprevalence in Children from Western Romania, March to June 2021
inferred← citeshttps://doi.org/10.1093/cid/ciac469openalex-snapshot
Association of Trends in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Seroprevalence and State-Issued Nonpharmaceutical Interventions: United States, 1 August 2020 to 30 March 2021
inferred← citeshttps://doi.org/10.1093/ije/dyab217openalex-snapshot
Estimated SARS-CoV-2 infection rate and fatality risk in Gauteng Province, South Africa: a population-based seroepidemiological survey
inferred← citeshttps://doi.org/10.1093/ofid/ofaf415openalex-snapshot
Comparison of Infection-Induced SARS-CoV-2 Seroprevalence Across Large-Scale Residual Samples From Blood Donors, Commercial Laboratories, and Health Checkups in Japan, 2023
inferred← citeshttps://doi.org/10.1101/2021.11.16.21266360openalex-snapshot
Impact of SARS-CoV-2 Vaccines on Covid-19 Incidence and Mortality in the United States
inferred← citeshttps://doi.org/10.1101/2022.03.27.22273000openalex-snapshot
Nationwide Effectiveness of First and Second SARS-CoV2 Booster Vaccines during the Delta and Omicron Pandemic Waves in Hungary (HUN-VE 2 Study)
inferred← citeshttps://doi.org/10.1101/2024.03.08.24303942openalex-snapshot
Prevalence and seroprevalence of COVID-19 infection among older people: A scoping review based on population-based studies in 2020-2022
inferred← citeshttps://doi.org/10.1109/ijcnn55064.2022.9892983openalex-snapshot
Acceptance and Perception of Covid-19 Vaccination for Children
inferred← citeshttps://doi.org/10.1111/irv.13182openalex-snapshot
Evolution of seroprevalence to SARS‐CoV‐2 in blood donors in Sarajevo Canton, Federation of Bosnia and Herzegovina: Cross‐sectional and longitudinal studies
inferred← citeshttps://doi.org/10.1111/irv.70053openalex-snapshot
The Second Round of a Population‐Based Seroprevalence Study of Anti–SARS‐CoV‐2 Antibodies and COVID‐19 Vaccination Assessment in the Republika Srpska, Bosnia and Herzegovina
inferred← citeshttps://doi.org/10.1128/spectrum.00691-24openalex-snapshot
School mask policies and SARS-CoV-2 seroprevalence among school-age children—United States, September to December 2021
inferred← citeshttps://doi.org/10.1128/spectrum.00876-23openalex-snapshot
Seroprevalence of COVID-19 in Oran: Cross-Sectional Study
inferred← citeshttps://doi.org/10.1128/spectrum.01131-21openalex-snapshot
A Highly Sensitive and Specific SARS-CoV-2 Spike- and Nucleoprotein-Based Fluorescent Multiplex Immunoassay (FMIA) to Measure IgG, IgA, and IgM Class Antibodies
inferred← citeshttps://doi.org/10.1136/bmjophth-2020-000688openalex-snapshot
Testing for SARS-CoV-2 seroprevalence: experiences of a tertiary eye centre
inferred← citeshttps://doi.org/10.1155/2021/9081491openalex-snapshot
High Seroprevalence of SARS-CoV-2 (COVID-19)-Specific Antibodies among Healthcare Workers: A Cross-Sectional Study in Guilan, Iran
inferred← citeshttps://doi.org/10.1183/16000617.0278-2024openalex-snapshot
The role of evidence-based medicine in the media: misinformation and the COVID-19 lesson
inferred← citeshttps://doi.org/10.1186/s12879-022-07031-zopenalex-snapshot
SARS-CoV-2 antibody seroprevalence in Lebanon: findings from the first nationwide serosurvey
inferred← citeshttps://doi.org/10.1186/s12879-024-09013-9openalex-snapshot
Enhancing detection of SARS-CoV-2 re-infections using longitudinal sero-monitoring: demonstration of a methodology in a cohort of people experiencing homelessness in Toronto, Canada
inferred← citeshttps://doi.org/10.1186/s12916-023-02802-0openalex-snapshot
Relative role of border restrictions, case finding and contact tracing in controlling SARS-CoV-2 in the presence of undetected transmission: a mathematical modelling study
inferred← citeshttps://doi.org/10.1186/s12992-022-00805-9openalex-snapshot
Analysis of the COVID-19 pandemic: lessons towards a more effective response to public health emergencies
inferred← citeshttps://doi.org/10.1214/21-sts844openalex-snapshot
Confidence Intervals for Seroprevalence
inferred← citeshttps://doi.org/10.12688/f1000research.75891.1openalex-snapshot
Likely community transmission of COVID-19 infections between neighboring, persistent hotspots in Ontario, Canada
inferred← citeshttps://doi.org/10.1371/journal.pmed.1004107openalex-snapshot
Global SARS-CoV-2 seroprevalence from January 2020 to April 2022: A systematic review and meta-analysis of standardized population-based studies
inferred← citeshttps://doi.org/10.1371/journal.pmen.0000410openalex-snapshot
The association between depressive symptoms and antibody response following SARS-CoV-2 vaccination among central North Carolina residents
inferred← citeshttps://doi.org/10.1371/journal.pntd.0009945openalex-snapshot
Seroprevalence of anti-SARS-CoV-2 IgG at the first epidemic peak in French Guiana, July 2020
inferred← citeshttps://doi.org/10.1371/journal.pone.0252617openalex-snapshot
Global seroprevalence of SARS-CoV-2 antibodies: A systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1371/journal.pone.0261931openalex-snapshot
Seroprevalence of antibodies against SARS-Cov-2 in the high impacted sub-district in Jakarta, Indonesia
inferred← citeshttps://doi.org/10.1371/journal.pone.0280276openalex-snapshot
Seroprevalence of anti-SARS-CoV-2 specific antibodies in vaccinated and vaccine naïve adult Nigerians
inferred← citeshttps://doi.org/10.1371/journal.pone.0300782openalex-snapshot
Does coronavirus disease 2019 history alone increase the risk of postoperative pulmonary complications after surgery? Prospective observational study using serology assessment
inferred← citeshttps://doi.org/10.1371/journal.pone.0301830openalex-snapshot
Impact of SARS-CoV-2 vaccines on Covid-19 incidence and mortality in the United States
inferred← citeshttps://doi.org/10.1371/journal.pone.0311287openalex-snapshot
Spectrum of COVID-19 cases in Arkhangelsk, Northwest Russia: Findings from a population-based study linking serosurvey, registry data, and self-reports of symptoms
inferred← citeshttps://doi.org/10.1515/cclm-2022-0037openalex-snapshot
Continuous monitoring of SARS-CoV-2 seroprevalence in children using residual blood samples from routine clinical chemistry
inferred← citeshttps://doi.org/10.1515/jpm-2021-0309openalex-snapshot
COVID-19 in pregnancy: where are we now?
inferred← citeshttps://doi.org/10.15446/revfacmed.v69n2.96644openalex-snapshot
Reflexiones críticas sobre el Índice de resiliencia epidemiológica municipal utilizado para la toma de decisiones de política pública en el control de la pandemia por COVID-19 en Colombia
inferred← citeshttps://doi.org/10.17269/s41997-022-00622-yopenalex-snapshot
Seroprevalence of SARS-CoV-2 antibodies among blood donors in Québec: an update from a serial cross-sectional study
inferred← citeshttps://doi.org/10.17816/humeco108116openalex-snapshot
Prevalence assessment adjusted for laboratory test performance using an example of the COVID-19 serological tests
inferred← citeshttps://doi.org/10.1787/04364681-enopenalex-snapshot
Health expenditure by type of service, 2019
inferred← citeshttps://doi.org/10.1787/04ad53c5-enopenalex-snapshot
Child malnutrition (including undernutrition and overweight)
inferred← citeshttps://doi.org/10.1787/0632cea5-enopenalex-snapshot
Prevalence of overweight amongst children under age 5, latest year available
inferred← citeshttps://doi.org/10.1787/08e88726-enopenalex-snapshot
Doctor consultations per capita and healthy life expectancy at birth, latest year available
inferred← citeshttps://doi.org/10.1787/0b7f8c27-enopenalex-snapshot
Financing of health care from government and compulsory health insurance schemes
inferred← citeshttps://doi.org/10.1787/0c8ed61f-enopenalex-snapshot
Age‑standardised prevalence estimates for current tobacco use amongst persons aged 15 and above, by sex, 2020
inferred← citeshttps://doi.org/10.1787/10d66a76-enopenalex-snapshot
Out-of-pocket spending as share of final household consumption, 2019 (or nearest year)
inferred← citeshttps://doi.org/10.1787/154b3066-enopenalex-snapshot
Psychiatrists, per 100 000 population, 2020 or latest year available
inferred← citeshttps://doi.org/10.1787/16da0acb-enopenalex-snapshot
Health expenditure by government scheme and compulsory insurance scheme as a share of GDP, 2010 and 2019
inferred← citeshttps://doi.org/10.1787/171a8522-enopenalex-snapshot
Average length of stays for acute care in hospitals, latest year available
inferred← citeshttps://doi.org/10.1787/182444bf-enopenalex-snapshot
Health expenditure by financing scheme
inferred← citeshttps://doi.org/10.1787/18968603-enopenalex-snapshot
Change in the proportion of malaria cases not treated, 2000‑20
inferred← citeshttps://doi.org/10.1787/1b9c8ca6-enopenalex-snapshot
Provision of care during pregnancy and birth, 2021 or latest year available
inferred← citeshttps://doi.org/10.1787/1db62250-enopenalex-snapshot
Composition of out-of-pocket spending on health, by type of service, 2019 (or nearest year)
inferred← citeshttps://doi.org/10.1787/204a68dd-enopenalex-snapshot
Excess mortality by age group, 2020
inferred← citeshttps://doi.org/10.1787/22633d95-enopenalex-snapshot
Prevalence of current tobacco use amongst youth aged 13 to 15, by sex, latest available year
inferred← citeshttps://doi.org/10.1787/233577ce-enopenalex-snapshot
Doctor providing easy-to‑understand explanations, 2010 and 2020 (or nearest year)
inferred← citeshttps://doi.org/10.1787/2ad665be-enopenalex-snapshot
Congestive heart failure hospital admission in adults, 2009, 2019 (or nearest year) and 2020
inferred← citeshttps://doi.org/10.1787/2d59724a-enopenalex-snapshot
Survival to age 65 (% of cohort), by sex, 2020
inferred← citeshttps://doi.org/10.1787/2dc9b16a-enopenalex-snapshot
Screening, survival and mortality for breast cancer
inferred← citeshttps://doi.org/10.1787/30a3559e-enopenalex-snapshot
Mortality following ischaemic stroke
inferred← citeshttps://doi.org/10.1787/327c6e0e-enopenalex-snapshot
Diet and physical activity among adolescents
inferred← citeshttps://doi.org/10.1787/328e79f5-enopenalex-snapshot
Antenatal care coverage and maternal mortality ratio, latest year available
inferred← citeshttps://doi.org/10.1787/35e5ecb7-fropenalex-snapshot
Adultes de 65 ans et plus déclarant un état de santé mauvais ou très mauvais, par revenu, pays européens, 2019 (ou année la plus proche)
inferred← citeshttps://doi.org/10.1787/369ca57e-enopenalex-snapshot
Ratio of nurses to doctors, 2019 (or nearest year)
inferred← citeshttps://doi.org/10.1787/37d10980-fropenalex-snapshot
Évolution des examens IRM dans divers pays, 2009‑20
inferred← citeshttps://doi.org/10.1787/391ca136-enopenalex-snapshot
Share of inpatient and community mental health service users who were treated with courtesy and respect by care providers, 2021 (or nearest year)
inferred← citeshttps://doi.org/10.1787/3a4fce05-enopenalex-snapshot
Mental health beds, per 100 000 population, 2020 or latest year available
inferred← citeshttps://doi.org/10.1787/3c17ffcc-enopenalex-snapshot
Radiation therapy equipment, latest year available
inferred← citeshttps://doi.org/10.1787/3cd5d881-enopenalex-snapshot
Neonatal mortality rates, 2000 and 2020
inferred← citeshttps://doi.org/10.1787/3f38731e-enopenalex-snapshot
All cancers, estimated mortality rates, 2000 and 2019
inferred← citeshttps://doi.org/10.1787/493e89b9-enopenalex-snapshot
Thirty-day mortality after admission to hospital for acute myocardial infarction based on linked data, 2009, 2019 (or nearest year) and 2020
inferred← citeshttps://doi.org/10.1787/4bf0141e-enopenalex-snapshot
Health expenditure by government and compulsory health insurance schemes as a share of total government expenditure, 2010 and 2019
inferred← citeshttps://doi.org/10.1787/4df915f1-enopenalex-snapshot
Children aged under 5 years with diarrhoea receiving oral rehydration solution and zinc supplements, latest year available
inferred← citeshttps://doi.org/10.1787/4e107e0b-enopenalex-snapshot
Remuneration of doctors (general practitioners and specialists)
inferred← citeshttps://doi.org/10.1787/4f9614b9-enopenalex-snapshot
Vaccination, survival and mortality for cervical cancer
inferred← citeshttps://doi.org/10.1787/501d07ca-enopenalex-snapshot
Life expectancy at birth, 2000 and 2019
inferred← citeshttps://doi.org/10.1787/52fc115e-enopenalex-snapshot
Changes in life expectancy at birth, 2019 and 2021
inferred← citeshttps://doi.org/10.1787/55c4136f-enopenalex-snapshot
Injuries, estimated mortality rates, 2000 and 2019
inferred← citeshttps://doi.org/10.1787/5710f362-enopenalex-snapshot
Access to basic sanitation, 2020 and change between 2010‑20
inferred← citeshttps://doi.org/10.1787/5c779fb7-enopenalex-snapshot
Adults rating their own health as good or very good, by income quintile, 2019 (or nearest year)
inferred← citeshttps://doi.org/10.1787/5d313b30-enopenalex-snapshot
Change in tuberculosis case notification rate, 2015‑20
inferred← citeshttps://doi.org/10.1787/5e1ae405-enopenalex-snapshot
National estimates of prevalence of depression or symptoms of depression, pre‑COVID‑19, 2020 and 2021
inferred← citeshttps://doi.org/10.1787/6377c1be-enopenalex-snapshot
All-cause mortality for all population by sex, age‑standardised, per 100 000 population, 2019
inferred← citeshttps://doi.org/10.1787/64856d2e-enopenalex-snapshot
Contraceptive prevalence, married or in-union women, latest available estimate
inferred← citeshttps://doi.org/10.1787/654cf452-enopenalex-snapshot
Health expenditure by type of service
inferred← citeshttps://doi.org/10.1787/692b9cff-enopenalex-snapshot
Hospital price levels, 2017, OECD average = 100
inferred← citeshttps://doi.org/10.1787/701ca3a6-enopenalex-snapshot
Estimated number of consultations per doctor, latest year available
inferred← citeshttps://doi.org/10.1787/755ff60c-enopenalex-snapshot
Expenditure on retail pharmaceuticals per capita, 2019 (or nearest year)
inferred← citeshttps://doi.org/10.1787/76e3c4d0-enopenalex-snapshot
Demand for family planning satisfied by modern methods by socio‑economic characteristics, selected countries, latest year available
inferred← citeshttps://doi.org/10.1787/7ab6cf3b-enopenalex-snapshot
Life expectancy at birth and survival rate to age 65
inferred← citeshttps://doi.org/10.1787/7ad98fa1-enopenalex-snapshot
Geographic distribution of doctors
inferred← citeshttps://doi.org/10.1787/7c16050f-enopenalex-snapshot
Percentage of adults searching for health information online, 2010 and 2020
inferred← citeshttps://doi.org/10.1787/82775c15-enopenalex-snapshot
Under age 5 mortality rates, 2000 and 2020 (or nearest year)
inferred← citeshttps://doi.org/10.1787/83c04a10-enopenalex-snapshot
Domestic general government health expenditure by type of service, 2019
inferred← citeshttps://doi.org/10.1787/84cdc102-enopenalex-snapshot
Under‑5 mortality and stunting prevalence, latest year available
inferred← citeshttps://doi.org/10.1787/86771d2e-enopenalex-snapshot
Employment growth by sector, OECD average, 2000‑19 (or nearest year)
inferred← citeshttps://doi.org/10.1787/86b13b0c-enopenalex-snapshot
Healthy life expectancy at birth by sex, 2019
inferred← citeshttps://doi.org/10.1787/87c6fbce-enopenalex-snapshot
Health expenditure per capita, 2019
inferred← citeshttps://doi.org/10.1787/8859bf20-enopenalex-snapshot
Children aged 6‑59 months who received full dose vitamin A supplementation, latest year available
inferred← citeshttps://doi.org/10.1787/8e46ed44-enopenalex-snapshot
People‑centredness of ambulatory care
inferred← citeshttps://doi.org/10.1787/909562ca-enopenalex-snapshot
Estimated maternal mortality ratio, 2019 and percentage change since 2000
inferred← citeshttps://doi.org/10.1787/9102d13c-enopenalex-snapshot
Infant mortality rates by socio-economic characteristic, selected countries and territories, nearest year
inferred← citeshttps://doi.org/10.1787/91983330-enopenalex-snapshot
COPD hospital admission in adults, 2009, 2019 (or nearest year) and 2020
inferred← citeshttps://doi.org/10.1787/919b5f62-enopenalex-snapshot
Indicator overview: Country dashboards and major trends
inferred← citeshttps://doi.org/10.1787/9414c451-enopenalex-snapshot
Share of the population aged 65 and over and 80 and over, 2019 and 2050
inferred← citeshttps://doi.org/10.1787/98f06f54-enopenalex-snapshot
People reporting a longstanding illness or health problem, by income quintile, 2019 (or nearest year)
inferred← citeshttps://doi.org/10.1787/999d42af-enopenalex-snapshot
Doctors per 1 000 population, latest year available
inferred← citeshttps://doi.org/10.1787/9dbcaf12-enopenalex-snapshot
Health expenditure by households’ out-of-pocket as a share of health expenditure, 2010 and 2019
inferred← citeshttps://doi.org/10.1787/9dc5a10a-enopenalex-snapshot
Population satisfied with the availability of quality health care in the area where they live, 2020 (or nearest year)
inferred← citeshttps://doi.org/10.1787/9e3cf8ad-enopenalex-snapshot
Care seeking and antibiotic treatment among children aged under 5 years with acute respiratory infection, latest year available
inferred← citeshttps://doi.org/10.1787/a9259851-enopenalex-snapshot
Drunkenness among 15‑year‑olds, by sex, 2017‑18
inferred← citeshttps://doi.org/10.1787/a9a91bc1-enopenalex-snapshot
Care for people with mental health disorders
inferred← citeshttps://doi.org/10.1787/b562d7d7-enopenalex-snapshot
Under age 5 mortality rates by socio‑economic and geographic factor, selected countries and territories, nearest year
inferred← citeshttps://doi.org/10.1787/bea767e9-enopenalex-snapshot
Prevalence of stunting and wasting amongst children under age 5, latest year available
inferred← citeshttps://doi.org/10.1787/c2a20e2d-enopenalex-snapshot
Cardiovascular disease, estimated mortality rates, 2000 and 2019
inferred← citeshttps://doi.org/10.1787/c4d7820a-enopenalex-snapshot
Mammographs, latest year available
inferred← citeshttps://doi.org/10.1787/c7467f62-enopenalex-snapshot
Health at a Glance: Asia/Pacific 2022
inferred← citeshttps://doi.org/10.1787/c87b8d54-enopenalex-snapshot
Mammography screening in women aged 50‑69 within the past two years, 2020 (or nearest year)
inferred← citeshttps://doi.org/10.1787/caaadb75-enopenalex-snapshot
Estimated number of people living with HIV, 2021
inferred← citeshttps://doi.org/10.1787/cb2e941e-enopenalex-snapshot
Proportions of cancer deaths, 2019
inferred← citeshttps://doi.org/10.1787/ccf9528d-enopenalex-snapshot
Women aged 15‑49 who reported problems in accessing care due to distance, by socio‑economic characteristics, latest year available
inferred← citeshttps://doi.org/10.1787/cd69f347-enopenalex-snapshot
Children aged under 5 years with diarrhoea receiving continued feeding and oral rehydration therapy, latest year available
inferred← citeshttps://doi.org/10.1787/cdf9f0be-enopenalex-snapshot
Breast cancer five‑year net survival, women diagnosed during 2000‑04 and 2010‑14
inferred← citeshttps://doi.org/10.1787/cefad7e8-enopenalex-snapshot
Ratio of people aged 15‑64 to people aged over 65 years, 2021 and 2050
inferred← citeshttps://doi.org/10.1787/d2284f6f-enopenalex-snapshot
Knee replacement surgery, 2019 (or nearest year)
inferred← citeshttps://doi.org/10.1787/d82b5284-enopenalex-snapshot
Proportion of chronic opioid users in the adult population, 2019 (or nearest year) and 2020
inferred← citeshttps://doi.org/10.1787/db069762-enopenalex-snapshot
Nurses working in mental health sector, per 100 000 population, 2020 or latest year available
inferred← citeshttps://doi.org/10.1787/db24585d-enopenalex-snapshot
In-hospital case‑fatality rates within 30 days after admission for ischemic stroke, patients 45 years old and over, 2009 and 2019 (or nearest years)
inferred← citeshttps://doi.org/10.1787/db85d54f-enopenalex-snapshot
Self-reported overweight (including obesity) rates among adults, by sex, selected countries, 2019 (or nearest year)
inferred← citeshttps://doi.org/10.1787/dbc817a8-enopenalex-snapshot
Gross fixed capital formation in the health care sector as a share of GDP, 2019
inferred← citeshttps://doi.org/10.1787/dc962bd7-enopenalex-snapshot
Infants aged 6‑8 months with solid, semi-solid and soft-foods, selected countries and territories, latest year available
inferred← citeshttps://doi.org/10.1787/dd438827-enopenalex-snapshot
Births attended by skilled health professionals, by socio‑economic and geographic factors, latest year available
inferred← citeshttps://doi.org/10.1787/e3ef8297-enopenalex-snapshot
Hospital beds per 1 000 population and hospital discharges per 1 000 population, latest year available
inferred← citeshttps://doi.org/10.1787/e84827b6-enopenalex-snapshot
Tuberculosis treatment success for new and relapse TB cases, 2019
inferred← citeshttps://doi.org/10.1787/ea493f36-enopenalex-snapshot
Vaccination coverage for human papillomavirus vaccine, complete schedule, females by age 15 (15HPVc), 2018‑20
inferred← citeshttps://doi.org/10.1787/efbe2d7a-enopenalex-snapshot
In-hospital case‑fatality rates within 30 days after admission for acute myocardial infarction, patients 45 years old and over, 2009 and 2019 (or nearest years)
inferred← citeshttps://doi.org/10.1787/f08f8e17-fropenalex-snapshot
Consommation de médicaments pour certaines affections chroniques, 2000, 2019, et 2020 (ou années les plus proches)
inferred← citeshttps://doi.org/10.1787/f104006a-enopenalex-snapshot
Foreign body left in during procedure, 2019 (or nearest year) and 2020
inferred← citeshttps://doi.org/10.1787/f116876e-fropenalex-snapshot
Évolution des chirurgies de remplacement de la hanche dans divers pays de l’OCDE, 2009‑20
inferred← citeshttps://doi.org/10.1787/f142af6d-enopenalex-snapshot
Vaccination coverage for measles-containing vaccine, first dose (MCV1), 2021
inferred← citeshttps://doi.org/10.1787/f15f3399-enopenalex-snapshot
Annual average growth in retail and hospital pharmaceutical expenditure, in real terms, 2010‑19 (or nearest years)
inferred← citeshttps://doi.org/10.1787/f2ea383a-enopenalex-snapshot
Proportions of age‑standardised all-cause mortality rate by causes of deaths, 2019
inferred← citeshttps://doi.org/10.1787/f3de457b-enopenalex-snapshot
Cervical cancer: Age‑standardised five‑year net survival, 2000‑04 and 2010‑14
inferred← citeshttps://doi.org/10.1787/f3f669eb-enopenalex-snapshot
Changes in malaria incidence rate, 2010‑20
showing the first 200 of 251 · page through all 251
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.